- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT07837089
Increasing Engagement With Digital Behavioral Health
Development of a Peer Digital Coach Intervention to Increase Adolescent and Young Adult Cancer Survivors' Engagement With a Digital Behavioral Health Intervention
This is a phased mixed-methods behavioral intervention study that will develop and test Mindful Peer Coach, a peer-supported mindfulness program for adolescent and young adult (AYA) cancer survivors. Phase 1 is a formative qualitative study designed to identify survivor-reported needs and preferences for increasing engagement with a mindfulness meditation app. Phase 2 is a pilot intervention study that will examine the feasibility, acceptability, and preliminary engagement outcomes of the Mindful Peer Coach program using participant surveys, app-use data, peer-coach training, coaching sessions, weekly text-message check-ins, and exit interviews with survivors and coaches.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Typ studiów
Zapisy (Szacowany)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Gary Kwok, PhD
- Numer telefonu: 2018803057
- E-mail: gary.kwok@hmh-cdi.org
Lokalizacje studiów
-
-
New Jersey
-
Nutley, New Jersey, Stany Zjednoczone, 07110
- HMH Center for Discovery and Innovation
-
Kontakt:
- Gary Kwok, PhD
- Numer telefonu: 201-880-3057
- E-mail: gary.kwok@hmh-cdi.org
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- at least one year from treatment completion
- ability to speak conversational English,
- per self-report, not being treated for posttraumatic stress disorder (PTSD), psychosis, or epilepsy/seizures.
- have experience with mindfulness and/or be willing to attend training and supervision sessions (only for coaches)
- at least two years from treatment completion (only for coaches) ;
Exclusion Criteria:
- outside age range
- closer to treatment completion than specified above
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie podtrzymujące
- Przydział: Nie dotyczy
- Model interwencyjny: Zadanie dla jednej grupy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Mindful Peer Coaching
Mindful Peer Coach consists of 1) live virtual and 2) text message coaching. |
Participants will complete six structured weekly videoconference sessions designed to cultivate mindfulness practice and increase engagement with the Happier Meditation app. Each session follows a standardized framework outlined in the training manual to ensure consistency and fidelity. Between sessions, coaches will provide support and accountability via text messaging. The frequency of messages will be determined collaboratively during Session 1. Each exchange begins with a previously tested mindfulness message, followed by tailored responses to reinforce practice, address questions, and sustain engagement. |
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Minutes use per day (User engagement)
Ramy czasowe: Minutes used per day will be captured daily through the app and summarized weekly across the full 3-month study period, including the 8-week intervention phase
|
Minutes use per day with the mindfulness-based mobile app obtained from the Happier Meditation dashboard. |
Minutes used per day will be captured daily through the app and summarized weekly across the full 3-month study period, including the 8-week intervention phase
|
|
Number of days used per week (User engagement)
Ramy czasowe: Number of days used per week will be captured daily through the app and summarized weekly across the full 3-month study period, including the 8-week intervention phase.
|
Number of days used per week with the mindfulness-based mobile app obtained from the Happier Meditation dashboard. |
Number of days used per week will be captured daily through the app and summarized weekly across the full 3-month study period, including the 8-week intervention phase.
|
|
Depression
Ramy czasowe: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Depression symptoms will be assessed using the PROMIS Depression measure. PROMIS Depression is an 8-item scale with each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Anxiety
Ramy czasowe: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Anxiety symptoms will be assessed using the PROMIS Anxiety measure. PROMIS Anxiety is an 7-item scale with each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 7 to 35 with higher scores indicating greater severity of anxiety. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Mindfulness
Ramy czasowe: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Mindfulness will be assessed using the Mindful Attention Awareness Scale measure. Your score falls into a range of 1 to 6, calculated by taking the average of all 15 responses. Higher average scores indicate greater overall mindfulness. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Emotion Regulation
Ramy czasowe: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Emotion Regulation will be assessed using the emotional experience subscale from the Emotion Regulation Questionnaire (ERQ) measure. The Emotion Regulation has 6 items on a 7-point Likert scale, with 1 indicating "strongly disagree" and 7 indicating "strongly agree" ranging from 6 to 42 (computed as the mean of the 6 items). Higher scores indicate a greater tendency to alter how you think about a situation to change its emotional impact. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Positive and Negative Emotions
Ramy czasowe: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Positive and Negative Emotions will be assessed using I-PANAS-SF (International Positive and Negative Affect Schedule Short-Form). It is a 10-item psychological tool that assesses affect. It evaluates both Positive Affect and Negative Affect on two separate 5-item subscales. Each of the 10 emotions is rated on a 5-point Likert scale, resulting in score ranges of 5 to 25 for both the Positive and Negative subscales. Higher scores indicate higher levels of that specific effect. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Distress
Ramy czasowe: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Distress will be assessed using the Perceived Stress Scale. The Perceived Stress Scale (PSS-10) is a 10 item scale that has a total score range from 0 to 40, with higher scores indicating higher levels of perceived stress. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Overall Wellbeing
Ramy czasowe: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Overall Wellbeing will be assessed using the PROMIS Global Health scale. For the standard PROMIS Global Health (PROMIS-GH-10) assessment, the 10 items produce two distinct summary scales: Global Physical Health and Global Mental Health. Because both subscales are made up of 4 items measured on a 1-5 point scale, the raw score range for each subscale is 4 to 20. While raw scores are simply the sum of your responses, they are not used directly to interpret health status. Instead, raw scores are converted into standardized T-scores using an established lookup algorithm: A T-score of 50 represents the average health of the U.S. general population. Every 10 points away from 50 equates to one standard deviation. Higher T-scores indicate better self-reported health, regardless of whether it is the physical or mental subscale. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
|
Sleep Disturbance
Ramy czasowe: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Sleep Disturbance will be assessed using the PROMIS Sleep Disturbance scale. The raw score range for the PROMIS Sleep Disturbance Scale 4-Item Short Forms: is generally 4 to 20. Higher raw scores correspond to a greater severity of sleep disturbance. These raw scores are then converted into a standardized T-score (where the general U.S. population average is 50, with a standard deviation of 10) using PROMIS Standardized Lookup Tables. |
Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Exit Interview
Ramy czasowe: At the end of the 8-week intervention period
|
Qualitative feedback collected through semi-structured exit interviews; no quantifiable data will be generated. Themes will be identified and presented using descriptive statistics. |
At the end of the 8-week intervention period
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Śledczy
- Główny śledczy: Gary Kwok, PhD, Hackensack Meridian Health Center for Discovery and Innovation
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Szacowany)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Inne numery identyfikacyjne badania
- Pro2024-0069
- K01CA308858 (Grant/umowa NIH USA)
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .